Diagnosing and defining MASLD in people living with chronic hepatitis B
Emily Martyn, Alejandro Arenas-Pinto, Richard Gilson, Nomathemba Chandiwana, Stuart Flanagan, Douglas MacDonald, Emmanuel A Tsochatzis, W D Francois Venter, Jennifer Manne-Goehler, Philippa C Matthews · 2026
Read Diagnosing and defining MASLD in people living with chronic hepatitis B by Emily Martyn, Alejandro Arenas-Pinto, Richard Gilson, Nomathemba Chandiwana, Stuart Flanagan, Douglas MacDonald, Emmanuel A Tsochatzis, W D Francois Venter, Jennifer Manne-Goehler, Philippa C Matthews (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13156279.txt.
Description
Emily Martyn and co-authors review how fatty liver disease is diagnosed in people who also live with chronic hepatitis B, in a 2026 paper. Both conditions feed the global burden of liver disease. How they interact is poorly understood. Shifting disease names and uneven use of tests have muddied the picture.
The review gathers evidence on tests that spot fatty liver and its scarring in this group. It weighs blood scores, scans, and other tools side by side. The authors call for shared definitions and consistent diagnosis. They also urge better monitoring, fairer access to care, and risk sorting that fits global populations. Clearer rules would help clinics act earlier.
Catalog record
| CREATOR | Emily Martyn, Alejandro Arenas-Pinto, Richard Gilson, Nomathemba Chandiwana, Stuart Flanagan, Douglas MacDonald, Emmanuel A Tsochatzis, W D Francois Venter, Jennifer Manne-Goehler, Philippa C Matthews |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |